Step-by-step Individual Intensification of Therapy for Type 2 Diabetes Mellitus. What is Further Choice after Metformin? (Literature Review)
Journal Title: Міжнародний ендокринологічний журнал - Year 2015, Vol 2, Issue 66
Abstract
Metformin — first-line drug for the treatment of diabetes mellitus (DM) type 2, the use of which reduces the progression of carbohydrate metabolism disorders and helps to reduce mortality rates. The progressive course of DM type 2 leads to the fact that patients, in which initial therapy contained only metformin, ultimately required step-by-step addition of other glucose-lowering drugs to achieve and maintain glycemic control. This literature review examines different approaches to step-by-step individual intensification of therapy for DM type 2. The most popular and most studied combination aimed at both defects determining the development of metabolic disorders in DM type 2 (relative insulin deficiency and insulin resistance) is a combination of metformin with sulfonylurea agents. Glimepiride has a unique combination of insulin secretagogue («careful» stimulation) and insulin sensitizing properties at neutral effect on body weight and lower the risk of hypoglycemia. Therefore, glimepiride today is regarded as the best choice in patients with DM type 2 in the presence of cardiovascular risk compared with other sulfonylurea drugs.
Authors and Affiliations
І. V. Pankiv
Application of the Original L-Ornithine-L-Aspartate in Patients with Complex Cardiovascular Disease and Type 2 Diabetes Mellitus
The article deals with the treatment of nonalcoholic fatty liver disease as a complication in patients with complex cardiovascular disease and type 2 diabetes mellitus. The data from the studies on the effect of Hepa-Mer...
Assessment of somatotropic function in children with syndrome of biologically inactive growth hormone against a background of clonidine and insulin stimulation tests
Background. Growth pathology caused by somatotropic insufficiency is one of the most urgent problems in pediatric endocrinology. An increase in the growth hormone (GH) level less than 10 ng/ml was traditionally consider...
Disorders of Insulin Synthesis and Secretion in Type 2 Diabetic Suffers after Disaster on ChNPS
There have been demonstrated the results of observation of 60 patients with type 2 diabetes mellitus divided into groups: the I one consisted of participants in the rectification of the consequences of the accident (PRCA...
Primary Hyperparathyroidism: Etiology, Pathogenesis, Clinical Picture, Diagnosis, Treatment, Quality of Life (Review of Literature)
The author provide a literature review of the data for the last 10–15 years on the problem of primary hyperparathyroidism (PHPT). PHPT was first described in 1943, but interest to the diseases of the parathyroid glands g...
Impaired Glucose Homeostasis in Patients with Coronary Artery Disease: Changing Views for 40 Years
An analysis of two researches of the department spaced 40 years apart — «Diagnosis and treatment of latent forms of diabetes mellitus in coronary atherosclerosis in men» (Khaletskyi M.Ye., 1975) and «Peculiarities of the...